简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-09-09 15:08 Hovione Appoints Stefan Doboczky as Chief Executive Officer
2026-09-04 14:33 Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing
2026-09-03 12:17 Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience
2026-09-02 14:04 BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines
2026-09-02 10:18 Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays
2026-09-01 14:43 Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis
2026-09-01 13:49 BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer
2026-08-31 11:16 Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera
2026-08-31 10:33 Novotech Strengthens Presence in Japan with Opening of Tokyo Office
2026-08-27 11:36 BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA
2026-08-27 10:27 NIPPON KINZOKU Establishes Mass Production of Ultra-Thin and Narrow Stainless Steel for Insulin Needles
2026-08-25 10:10 Shape Memory Medical Secures $10 Million Financing Led by August Global Partners to Advance Aortic Clinical Programs
2026-08-24 15:29 ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
2026-08-24 10:47 InterSystems Asia READY 2026 to Showcase AI-Ready Healthcare
2026-08-19 12:29 BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
2026-08-12 09:44 Align Technology Prevails in China Patent Infringement Action Against Angelalign
2026-08-11 16:02 BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
2026-08-11 13:08 Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping
2026-08-10 14:06 ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
2026-08-06 10:00 U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

Business Wire Weibo

Press Releases

Latest Releases